Stricture and stenosis of cervix uteri
ICD-10 N88.2 · ICD-11 GA15.4

Treatment of Cervical Stricture and Stenosis in Postmenopausal Status or with GnRH Analog Therapy

Clinical Scenario

This protocol addresses cervical stricture and stenosis in patients who are postmenopausal or receiving treatment with gonadotropin-releasing hormone (GnRH) analogs — both states associated with a hypoestrogenic environment that substantially affects the approach to preprocedural cervical management.

Why Postmenopause and GnRH Analog Therapy Change Management

In postmenopausal women and those treated with GnRH analogs, the hypoestrogenic state directly impairs standard cervical preparation. Prostaglandins depend on estrogen to exert their cervical ripening effect; when estrogen is absent or suppressed, the pharmacological response is reduced, requiring a specifically adapted preprocedural strategy.

Treatment Approach (Partial Overview)

The protocol involves preprocedural cervical ripening with a specific pretreatment step designed to restore the pharmacological conditions necessary for effective cervical preparation in this hypoestrogenic population — with an alternative mechanical option also available.

The complete regimen — including agent selection, sequencing, and all procedural details — is available via the link below.

Clinical Goal

Restoration of patency of the cervical canal to allow successful cervical dilation.

Instant Access to Structured Evidence-Based Regimens

References

  1. In postmenopausal women and those treated with gonadotropin-releasing hormone analogs, misoprostol has a decreased effect since prostaglandins require estrogen to generate their cervical ripening effects, and postmenopausal patients are in a hypoestrogenic state.
  2. Thomas et al. in a randomized study in postmenopausal women, administered 400 µg of misoprostol or placebo orally 12 and 24 h before operative hysteroscopy, reporting that misoprostol requires a longer duration to achieve clinical efficacy.
  3. In an observational comparative study, Casadei et al. highlighted the relevance of estrogen pretreatment in allowing the effect of misoprostol on cervical ripening.
  4. The insertion of laminaria stems before the procedure is intended to simplify the cervical dilation.
  5. The main objective of both medical and surgical treatments for cervical stenosis is to restore the patency of the cervical canal.

DOI: 10.1007/s00404-023-07126-1

View source ↗